TrianglePembrolizumab + Image-Guided Surgery (NCT03760575)
Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for malignant pleural mesothelioma, a cancer of the lining of the lungs, in adults.
The idea: add the immunotherapy drug pembrolizumab, given by vein before and after surgery, to standard care. Surgery uses indocyanine green image guidance to help remove the tumor, followed by the chemotherapy drugs cisplatin and pemetrexed.
This phase 1 study plans 20 patients and looks at safety, feasibility and early signs of benefit. At the University of Pennsylvania's Abramson Cancer Center, Corey Langer leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.